Status:
COMPLETED
Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions
Lead Sponsor:
State University of New York - Upstate Medical University
Collaborating Sponsors:
Orthovita d/b/a Stryker
Conditions:
Bone Diseases
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is a prospective randomized study comparing Vitoss alone versus Vitoss with bone marrow aspirate in benign bone lesions.
Detailed Description
Bone graft obtained from a patient's own bone (autogenous), usually around the pelvis, is currently considered the gold standard for bone grafting material. It provides a structural scaffold on which ...
Eligibility Criteria
Inclusion
- Patients with a benign bone lesion requiring surgical curettage
Exclusion
- Patients with infection, bone marrow disorders, or other contraindications to use of supplemental bone marrow aspiration as well as those who prefer autologous or allogeneic graft material alone (without synthetic filler) would be excluded.
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT00147823
Start Date
December 1 2004
End Date
December 1 2011
Last Update
June 8 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SUNY Upstate Medical University
Syracuse, New York, United States, 13210